Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Berries may boost cell talk: new study investigates

NCT ID NCT07381933

Knowledge-focused Sponsor: University of Oulu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how eating cloudberries and lingonberries affects tiny particles called extracellular vesicles, which cells use to communicate. Sixty healthy adults will eat these berries daily for a week. Researchers will check changes in gut bacteria, immune cells, and blood signals to see if berries improve cell messaging.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cloudberries and lingonberries
What this could lead to
If successful, this could reveal how berries influence cell communication and gut health, potentially guiding future dietary recommendations.
What could go wrong
This is a small, early-stage study in healthy people, so results may not apply to those with illnesses. It only looks at short-term effects over 7 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-50 * Individuals of all heights and weights and both female and male sexes are accepted * Written informed consent is required from all study participants * Use of probiotics is allowed, but the usage will be reported Exclusion Criteria: * Known or suspected allergy to cloudberries or lingonberries * Current dermatological or gastrointestinal conditions requiring treatment or interfering the sampling * Renal failure * Type 1 or type 2 diabetes * Pregnancy * Immunodeficiency or any condition affecting the immune system, e.g. chronic viral infection * Ongoing antibiotic treatment or antibiotic treatment within the past 3 months * Immunosuppressive medication or other medication that can be influenced by the intervention

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Extracellular vesicles are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Extracellular vesicles Healthy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Oulu University Hospital

    RECRUITING

    Oulu, 90029, Finland

More trials for these conditions

Other studies related to the condition(s) this trial covers.